Literature DB >> 12126926

Acute hypervolemia lengthens red cell pulmonary transit time during exercise in endurance athletes.

G S Zavorsky1, K R Walley, G S Hunte, D C McKenzie, G P Sexsmith, J A Russell.   

Abstract

The purpose was to determine if acute plasma volume expansion (PVE) changed red-cell pulmonary transit time (PTT) during severe exercise. Twelve endurance athletes performed 6.5 min of severe cycling exercise on different days. Pentaspan [(500 ml, infusion condition, I] or placebo [(60 ml saline), non-infusion condition, N] were infused prior to exercise. Blood gas tensions, PTT, multigated acquisition (MUGA) derived cardiac output, and oxygen uptake were measured during exercise. PTT was measured during minute 3 of exercise by radionuclide cardiography. Arterial P(O(2)) (Pa(O(2))), and alveolar-arterial oxygen pressure difference (AaD(O(2))) at minute 3 of exercise did not differ between conditions. Mean PTT at minute 3 of exercise was 0.3 sec longer in the I condition (P=0.002). However, the change in PTT between conditions was not correlated to the change in either Pa(O(2)) or AaD(O(2)). We conclude that PVE slows (lengthens) PTT without affecting pulmonary gas exchange. Therefore, rapid PTT may not be related to hypoxemia during exercise.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126926     DOI: 10.1016/s1569-9048(02)00028-9

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  2 in total

1.  Intra-pulmonary shunt and pulmonary gas exchange during exercise in humans.

Authors:  Michael K Stickland; Robert C Welsh; Mark J Haykowsky; Stewart R Petersen; William D Anderson; Dylan A Taylor; Marcel Bouffard; Richard L Jones
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

Review 2.  Pulmonary gas exchange and acid-base balance during exercise.

Authors:  Michael K Stickland; Michael I Lindinger; I Mark Olfert; George J F Heigenhauser; Susan R Hopkins
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.